FRET is a well established method for cellular and subcellular imaging of protein interactions. However, FRET obligatorily necessitates fluorescence excitation with its concomitant problems of photobleaching, autofluorescence, phototoxicity, and undesirable stimulation of photobiological processes. A sister technique, bioluminescence resonance energy transfer (BRET), avoids these problems because it uses enzyme-catalyzed luminescence; however, BRET signals usually have been too dim to image effectively in the past. Using a new generation electron bombardment-charge-coupled device camera coupled to an image splitter, we demonstrate that BRET can be used to image protein interactions in plant and animal cells and in tissues; even subcellular imaging is possible. We have applied this technology to image two different protein interactions: (i) dimerization of the developmental regulator, COP1, in plant seedlings; and (ii) CCAAT/ enhancer binding protein ␣ (C/EBP␣) in the mammalian nucleus. This advance heralds a host of applications for imaging without fluorescent excitation and its consequent limitations.
I
nteractions among proteins are key to the performance of their cellular activity. Identifying the partners with which a protein associates has been a major approach, in addition to genetics, toward discovering the key components of a biological pathway. Moreover, quantifying and localizing these protein interactions are crucial to the ultimate understanding of how proteins accomplish their raison d'etre. Many different methods are available for measuring protein interactions (1) , but one of the most useful is based on Förster resonance energy transfer (2) . In particular, FRET is a well established resonance energy technique for monitoring protein interactions (3) . When two fluorophores (the ''donor'' and the ''acceptor'') with overlapping emission/absorption spectra are within Ϸ50 Å of one another and other conditions are met, the donor fluorophore is able to transfer its excited-state energy to the acceptor fluorophore. FRET can act as a ''molecular yardstick'' when two fluorophores of overlapping emission/absorption spectra are within a radius of Ϸ50 Å and other conditions are met. Therefore, if appropriate fluorophores are linked to proteins that interact with each other, the proximity of those proteins can be detected by FRET in living cells in which the fusion proteins are produced endogenously (3) . Thus, the presence or absence of FRET acts as a molecular yardstick.
However, because FRET demands that the donor fluorophore be excited by light, the practical usefulness of FRET can be limited by the concomitant consequences of that irradiation: photobleaching, autofluorescence, and direct excitation of the acceptor fluorophore. Furthermore, some tissues can be damaged by the excitation light or might be directly photoresponsive (e.g., retina and most plant tissues) so that a photobiologically regulated interaction can be disturbed by FRET. For these reasons, we developed a complementary technique, bioluminescence resonance energy transfer (BRET) (4) , that takes advantage of the natural phenomenon in which GFP participates (5) .
In BRET, the donor fluorophore of the FRET technique is replaced by a luciferase. In the presence of a substrate, bioluminescence emanating from the luciferase can excite the acceptor fluorophore if the luciferase and fluorophore are within a radius of Ϸ50 Å. BRET thereby avoids the problems of direct excitation while retaining the advantages of FRET. BRET also has the potential to outshine FRET for deep penetration of animal tissues (6) and for high-throughput screening because an internal light source is not required in the screening instrument and because BRET does not photobleach the energy donor (7) .
On the other hand, because the light emission from BRET generally is dim, it has been thought to be less suitable for imaging than is FRET (8, 9) . In particular, BRET has been thought to be ''not currently suitable for single-cell analyses and thus information on cellular distribution and spatial resolution cannot be provided'' with BRET (7) . Until now, that is. We have coupled a very sensitive charge-coupled device (CCD) camera with a Dual-View image splitter to display BRET localizations in highly autofluorescent plant tissues and cells. Here, we present the tissue localization for dimerization of the plant regulator of light signaling, constitutive photomorphogenesis 1 (COP1) protein. Furthermore, we are able to image the subcellular distributions of interactions of the CCAAT/enhancer binding protein ␣ (C/EBP␣) in single isolated mammalian cells. This advance augurs imaging applications that are not limited by problems associated with fluorescent excitation. A ''BRET ratio'' then is derived over the image to quantify the amount of resonance transfer from luciferase to fluorophore, and these BRET ratios will be expressed herein as ''YϬB'' or ''Y:B.'' Fig. 1 A-D depicts the BRET signal when Renilla luciferase (RLUC) is expressed alone in tobacco seedlings. RLUC luminescence is expressed strongly from root hairs as well as stems and weakly from cotyledons ( Fig. 1 B and C) . As expected, the luminescence image for RLUC in the blue window (Fig. 1B) is significantly brighter than that in the yellow window (Fig. 1C) , resulting in a BRET ratio over the entire seedling that is mostly Ͻ1.0 (average Y:B over the entire image ϭ 0.85 Ϯ 0.08 SD; Fig. 1D ). On the other hand, luminescence from the fusion protein RLUC⅐enhanced yellow fluorescent protein (EYFP), which exhibits BRET (4), shows a brighter luminescence in the yellow than in the blue (Fig. 1 F and G) , resulting in a BRET ratio over the seedling predominantly Ͼ1.0 (Y:B ϭ 1.31 Ϯ 0.15 SD; Fig. 1H ).
We previously showed in a nonimaging study that BRET could be used to measure the dimerization of COP1 protein, a repressor of light-regulated development in plants (10, 11) . Because that investigation was performed in onion epidermal cells, it could not demonstrate the localization of COP1 interaction among the tissues of seedlings/plants. Here, we use BRET to visualize the tissue localization of COP1 dimerization in tobacco seedlings with two independent COP1 fusion proteins; both fusion proteins are N-terminal fusions: RLUC⅐COP1 and EYFP⅐COP1 (10) . These constructs were not expressed as strongly in the tobacco seedlings as were RLUC and RLUC⅐EYFP, but they clearly were expressed in the rootlet and cotyledons ( Fig. 1 J-K) . The BRET ratio was high (Y:B ϭ 1.26 Ϯ 0.12 SD) wherever the RLUC⅐COP1 expression was strong enough to obtain a detectable luminescence image (Fig. 1L) . This result indicates that dimerization occurs for the photomorphogenesis-regulating protein COP1 throughout the seedling, even in tissues such as roots that do not normally receive strong illumination and therefore would not be expected to express pathways involved in light-regulated development.
BRET Imaging in Arabidopsis Tissues and Cells. Fig. 1 clearly shows that macroimaging of plant tissue BRET is possible. We decided to zoom in with an inverted microscope coupled with our EB-CCD/Dual-View on specific tissues and cells of Arabidopsis, the most widely used plant for genetic research. Fig. 2 illustrates the application of BRET to the cotyledons of seedlings (Fig. 2 A-I) and to a single isolated plant cell (Fig. 2 J-N) . Fig. 2 A shows spectra of whole Arabidopsis seedlings expressing RLUC or RLUC⅐EYFP. Fig. 2 B and C shows the emission of RLUCexpressing seedlings in the blue and the yellow, respectively. Fig.  2D shows the BRET ratio over the cotyledons, which generally is Ͻ1.0 (Y:B ϭ 0.58 Ϯ 0.02 SD), which corresponds well with that expected from the whole-seedling spectrum shown in Fig. 2 A. Fig. 2 E-I shows another cotyledon expressing the RLUC⅐EYFP fusion protein. By virtue of its EYFP moiety, this protein is fluorescent, and therefore the distribution of its fluorescence over the cotyledon can be visualized (Fig. 2F) . Assay of luminescence demonstrates that the yellow emission (Fig. 2H) is brighter than the blue emission (Fig. 2G ), resulting in a BRET ratio Ͼ1.0 (Y:B ϭ 1.18 Ϯ 0.05 SD; Fig. 2I ), as expected from the whole-seedling BRET spectrum (Fig. 2 A) .
We then extended BRET imaging to single Arabidopsis cells isolated from a suspension culture line and expressing the RLUC⅐EYFP fusion protein (Fig. 2 J-N) . As was the case for cotyledon tissue, single cells expressing RLUC⅐EYFP exhibit fluorescence (Fig. 2K ) and luminescence that is brighter in the yellow (Fig. 2M ) than in the blue (Fig. 2L ), resulting in a BRET ratio Ͼ1.0 (Fig. 2N) . RLUC⅐EYFP is localized in the cytoplasm (the outer ring) and the nucleus (the bulge at the 10 o'clock position of the ring) but is excluded from the large central vacuole that is characteristic of most plant cells.
Correction of BRET Signal in Differentially Absorbing Tissues. In our measurements of RLUC⅐EYFP emission in Escherichia coli (4) and mammalian cells (see below), the emission peaks in the blue versus the yellow windows have been approximately equal (i.e., Y:B Ϸ 1.0). Therefore, we initially were perplexed that the yellow peak was reproducibly higher when RLUC⅐EYFP was expressed in plant tissue (as in Fig. 2 A) . We considered the possibility that this was because of the fact that green plant tissue contains many pigments that might differentially absorb luminescence of different wavelengths. This hypothesis is easily tested because plants can be germinated and grown in darkness, resulting in ''etiolated'' or essentially nonpigmented tissue. When we measured the whole-plant emission spectrum of RLUC⅐EYFP from etiolated tobacco seedlings, we indeed found an emission spectrum that was closer to 1:1 for Y:B (Fig. 3A) . Green plant tissue contains pigments that absorb more strongly in the blue than in the green-yellow regions of the spectrum, as can be seen by the luminescence spectra normalized to 530 nm ( Fig. 3B ) and by absorption spectra of extracted plant tissue (Fig. 3C ). This information can be used to normalize spectra for use in quantitative BRET assays. For example, we calculate that the absorption at 480 nm is 1.27ϫ that at 530 nm (see SI Text), so we can correct our BRET images for this differential absorption, as illustrated in Fig. 3 . (4), and ''humanized'' RLUC (i.e., sequence optimized for human codon bias) (hRLUC)⅐Venus (optimized YFP) emission from mammalian cells (see Fig. 4I ). Note that after correction, the seedlings in Fig. 3 E and G show equivalent BRET ratios over the green cotyledon (red box areas) and nonpigmented root regions.
Subcellular Imaging of BRET Interactions in Single Mammalian Cells.
BRET imaging also is possible from single mammalian cells in serum-containing medium by using the coelenterazine analog ViviRen as the substrate for RLUC (see SI Text and SI Fig. 6 for a discussion of the relative merits of native coelenterazine versus its analogs as substrates for BRET imaging). Quantification of the average BRET ratios (YϬB Ϯ SD) over the entire images for these samples are as follows: for RLUC, YϬB ϭ 0.58 Ϯ 0.02 SD (n ϭ 6, including D); and for RLUC⅐EYFP, YϬB ϭ 1.18 Ϯ 0.05 SD (n ϭ 6, including I). Coelenterazine concentration was 10 M at 22°C. SD) over the image (Fig. 4D) . On the other hand, HEK293 cells transfected with the fusion protein hRLUC⅐Venus (Fig. 4 F-J) show a strong BRET ratio of 0.82 (Y:B ϭ 0.82 Ϯ 0.07 SD; Fig.  4I ). To determine whether the BRET ratio is perturbed by expression of noninteracting proteins, we coexpressed unfused hRLUC and unfused Venus and found a low BRET ratio that indicates no spurious interaction (Y:B ϭ 0.36; Fig. 4 K-O) . Furthermore, we have been able to image the subcellular distributions of interactions of the C/EBP␣ in single isolated mammalian cells. C/EBP␣ is a transcriptional factor that localizes to the heterochromatin in the nucleus and dimerizes (12, 13) . A C/EBP␣⅐hRLUC fusion protein localizes to the nucleus of mouse GHFT1 cells and demonstrates a low BRET ratio (Y:B ϭ 0.24 Ϯ 0.05 SD; Fig. 4 P-S) . When C/EBP␣⅐hRLUC is coexpressed with C/EBP␣⅐Venus, however, the nuclear expression consistently reveals a higher BRET ratio within the nucleus (Y:B ϭ 0.39 Ϯ 0.04 SD; Fig. 4 U-Y). These observations confirm FRET studies of C/EBP␣ dimerization in GHFT1 cells that display nuclear regions of increased C/EBP␣ interaction (12) . It is interesting to note that the fusion of C/EBP␣ to RLUC appears to inf luence the spectrum of RLUC emission slightly, as demonstrated by the reduction of the BRET ratio as compared with the RLUC control (Y:B ϭ 0.24 versus 0.32). This observation illustrates the importance of using the appropriate control for BRET studies. Coexpression of unfused hRLUC with Venus⅐C/EBP␣ is another control to demonstrate the absence of spurious interaction; as shown in Fig. 4CЈ , the BRET ratio of hRLUC essentially is the same (Y:B ϭ 0.30) in the cytoplasm as the hRLUC control in Fig. 4D (Y:B ϭ 0.32) despite the expression of Venus⅐C/EBP␣ that is localized prominently to the nucleus but is also found in the cytoplasm (Fig. 4DЈ) . Another interesting observation is that hRLUC or hRLUC⅐Venus sometimes appears to be excluded from the nucleus in mammalian cells (e.g., Fig. 4 G-J and AЈ-CЈ), whereas it entered the Arabidopsis nucleus (the bulge at the 10 o'clock position of the ring; Fig. 2 J-N) . However, when hRLUC or Venus is fused to C/EBP␣, it is able to translocate to the mammalian nucleus (Fig. 4 Q-S, V-Y, and DЈ) . Finally, the BRET ratio is independent of the brightness of the luminescence signal; thus, the BRET ratio is not inf luenced by the level of expression of donor (RLUC) or acceptor (e.g., Venus or YFP; see SI Text and SI Fig. 7 ).
Discussion
Fluorescence techniques have become the predominant methodology for imaging cells, subcellular organelles, and small pieces of tissue. This technology has blossomed, leading to fluorescence tools such as FRET, fluorescence photobleaching, fluorescence lifetime imaging, confocal microscopy, etc. (3). On the other hand, because of its exquisite sensitivity and independence from excitation, luminescence technology often is preferable for high-throughput screening (7). An additional advantage of BRET is that it is superior for deep penetration of animal tissues (6) . Luminescence is also favored over fluorescence for assays of promoter activity, especially for those involving temporal changes of promoter activity, because native luciferases tend to have a shorter half-life than native fluorescent proteins do and therefore are better reporters of time-dependent changes (14) [there are destabilized fluorescent proteins that have shorter half-lives, but they still are not as useful for time-course experiments in which cells are irradiated frequently, leading to phototoxicity (15) ]. Therefore, BRET outshines FRET in applications where fluorescence excitation is undesirable. The major limitation that has caused luminescence imaging to lag behind fluorescence imaging has been the fact that luminescence signals usually are much dimmer than fluorescence signals are. However, our application of a modified EB-CCD camera coupled with a microimager demonstrates that BRET now can be imaged at tissue, cellular, and even subcellular levels. At the subcellular level, we show that nuclear and cytoplasmic BRET signals can be visualized (Figs. 2 and 4) . With this technology, it should be possible to visualize mitochondrial and chloroplastidic BRET signals as well. We have applied this technology to image protein interaction of (i) COP1 in plant seedlings, and (ii) C/EBP␣ in the mammalian nucleus. We also show that tissues that absorb light differentially can be used for quantitative measurements of BRET by a correction using RLUC⅐EYFP emission profiles. Together with the demonstration that BRET imaging is possible in tissues of intact animals (6), our results enable a host of applications for imaging without fluorescent excitation, thereby avoiding the problems of photobleaching, autofluorescence, phototoxicity, and undesirable stimulation of photobiological processes.
Materials and Methods
Plant and Mammalian Cell Culture. Arabidopsis and tobacco plant seedlings were transformed with expression cassettes of P 35S ::RLuc, P 35S ::RLuc⅐EYFP, and P 35S ::RLuc⅐COP1 ϩ P 35S ::EYFP⅐COP1 (10). Plant seedlings were grown on 1/2 MS medium for 5-7 days (after germination) separately before measuring luminescence spectra and imaging. Single cells of Arabidopsis were generated from cell suspensions initiated from calli. Human HEK293 and mouse GHFT1 cells were grown in DMEM with 10% FBS at 37°C and transfected with plasmids using Lipofectamine 2000 (Invitrogen, Carlsbad, CA). After 24 h, cells were washed and resuspended in DMEM with 10% FBS for imaging. Plasmids were insertions into pcDNA3.1 with the transgenes expressed under the control of the CMV promoter P CMV . See SI Text for details.
BRET Methods. Methods for measuring protein interactions in populations of cells with BRET have been described for bacteria (4, 16) , plants (10, 17) , and mammalian cells (6, 18 -20) . In this study, substrates for RLUC were native coelenterazine (NanoLight, Pinetop, AZ), ViviRen/EnduRen (Promega, Madison, WI), or Deep Blue C (BioSignal; PerkinElmer, Waltham, MA). For spectral measurements of BRET emission, a QuantaMaster QM-7/SE (Photon Technology International, Birmingham, NJ) spectrophotometer was used; for luminescence spectral measurements, the excitation beam was blocked, and the slit width was set to 16 nm.
Imaging of BRET. BRET imaging was accomplished by using (i) a Dual-View microimager, and (ii) a modified EB-CCD camera. The Dual-View microimager (Optical Insights, Tucson, AZ) allows the simultaneous acquisition of luminescence images at two wavelengths. It consists of a dichroic mirror (in our case, to split at 505 nm with Q505LPxr) and interference filters to select for wavelengths Ͻ505 nm (HQ505SP; blue) and for wavelengths Ͼ505 nm (HQ505LP; yellow). Our EB-CCD camera had a GaAsP photocathode with low-ion feedback and cooling to Ϫ25°C (Hamamatsu Photonic Systems, Bridgewater, NJ) (see SI Text for details). The acquisition software was Photonics-WASABI (Hamamatsu). BRET imaging of plant seedlings was performed both in a lighttight box and through an inverted microscope. In the case of the light-tight box setup (used for Figs. 1 and 3) , the EB-CCD camera was coupled to the Dual-View to which a ϫ4 noninfinity-corrected microscopic objective had been attached, and the entire apparatus was enclosed in the light-tight box. This apparatus did not allow excitation of fluorescence. For plant seedlings, cells, and mammalian cells, the Dual-View and EB-CCD were attached to the bottom port of an IX-71 inverted microscope (Olympus America Inc., Melville, NY). This setup allows the measurement of fluorescence with an epifluorescence attachment (excitation 500/20 nm, emission 520 long pass). The entire IX-71 microscope was enclosed in a temperature-controlled (22-37°C) light-tight box. For low-power imaging (e.g., Fig. 2 B-I) , a Macro XLFLuor ϫ2 objective, numerical aperture (N.A.) 0.14 (Olympus) was used (optics arrangement 1), whereas for higher magnifications, a UPlanFl ϫ40 objective, N.A. 1.30 (oil immersion, Olympus) was used for Fig. 2 J-N (optics  arrangement 2) , or a Plan Apo ϫ60 objective, N.A. 1.45 (oil immersion, Olympus) was used for Fig. 4 (optics arrangement 3) . GV3101) (2, 3) . The tobacco cotransformation lines with two independent T-DNAs RLuc-COP1(N)/EYFP-COP1(N) were screened on gentamycin and kanamycin media. Both tobacco and Arabidopsis seedlings were grown on 1/2 MS medium for 7 and 5 days (after germination) separately before measuring luminescence spectra and imaging. Arabidopsis calli were induced by germinating seeds directly on the induction medium containing 0.5 mg/liter 2,4-D(2,4-dichlorophenoxyacetic acid), 2.0 mg/liter a-naphthaleneacetic acid (NAA), 0.5 mg/liter 6-BA(6-benzylaminopurine) (Sigma). Cell suspension lines were initiated by transferring the callus to 20 ml of fresh induction medium in a flask and placing it on a shaker (120 rpm, 22°C, 12-h light/12-h dark cycle) (4). Single cells of Arabidopsis were generated from these cell suspensions initiated from calli. BRET constructs were expressed under the control of the constitutive promoter CaMV 35S (P 35S ).
Mammalian Cell Culture and Transfection. Human HEK293 and mouse GHFT1 cells were grown in DMEM (Sigma) with 10% FBS at 37°C and transfected with plasmids using Lipofectamine 2000 (Invitrogen) as follows. Four micrograms of plasmids were mixed with 10 ml of Lipofectamine 2000 in 250 ml of OptiMEM medium. This mixture was added to cells in a 35-mm dish containing 2 ml of DMEM + 10% FBS. After 24-48 h, cells were washed and resuspended in DMEM with 10% FBS for imaging.
Plasmids were insertions into pcDNA3.1 with the transgenes expressed under the control of the CMV promoter P CMV . Venus YFP and C/EBPa244 were amplified from their original vectors by PCR. PCR primers were designed to create specific restriction enzyme sites in each PCR product. These fragments were purified and subcloned in the corresponding restriction sites into hRlucC1 (codon "humanized" pRlucC1 from Perkin-Elmer) or the pcDNA 3.1+ vector (Invitrogen) to create different plasmids that express hRluc•Venus, hRluc•C/EBPa244, and Venus•C/EBPa244 fusion proteins under the control of the CMV promoter P CMV .
Spectral Measurements. For spectral measurements of BRET emission, a QuantaMaster QM-7/SE (Photon Technology International, Birmingham NJ) spectrophotometer was used; for luminescence spectral measurements, the excitation beam was blocked and the slit width was set to 16 nm.
Imaging of BRET.
Methods for measuring protein interactions in populations of cells using BRET have been described for bacteria (5, 6) , plants (1, 7), and mammalian cells (8) (9) (10) (11) . Our imaging setup consisted of a Dual-View, an EB-CCD camera, and, in all figures except Fig. 1 , an inverted microscope. These components and arrangements are described below.
Dual-View microimager:
The Dual-View microimager (Optical Insights, Tucson AZ) allows us to collect images in two wavelength ranges simultaneously; therefore, a BRET ratio of emission in the two ranges can be calculated without the complication that the total luminescence signal may be changing over the time course of the exposure. The Dual-View includes a dichroic mirror that splits the image at 505 nm and short-pass/long-pass filters that refine the spectral distinction. The part numbers of the dichroic mirror and interference filters we used are as follows:
Filters: HQ505SP and HQ505LP
Dichroic mirror: Q505LPxr
Camera: We used a modified electron bombardment-charge-coupled device (EB-CCD) camera (Hamamatsu Photonic Systems, Bridgewater NJ); the modifications were a GaAsP photocathode with low ion feedback and increased photocathode cooling to -25°C. The low ion feedback was achieved by a special modification to the EB-CCD camera by Hamamatsu to remove the aluminum mask from the sensor that normally is included to avoid the "doublefocus phenomenon." In the case of low-light imaging, this problem is negligible. In addition, the camera is using full-frame transfer CCD, so it is possible to remove the mask. As a result, the sensor gets the same gain at a lower acceleration voltage. This low acceleration voltage reduces the ion feedback phenomenon drastically, improving performance for very low-light level imaging. Finally, the cooling of the photocathode to -25°C reduces the dark current of the photocathode. The acquisition software was Photonics-WASABI (Hamamatsu).
"Box" setup: In this arrangement, samples were enclosed in a light-tight box. The EB-CCD camera was coupled to the Dual-View image splitter, which was coupled directly to a non-infinity-corrected microscopic objective (Plan 4´, NA = 0.13 DL, 160/-or Plan 10´, NA = 0.30 DL, 160/0.17; Nikon). Fluorescence imaging was not possible when using this setup. Under these conditions, spontaneous YFP fluorescence or autofluorescence in the absence of coelenterazine (as might occur if there were a light leak) could not be detected in the light-tight box setup for 10-to 30-min exposures. After adding coelenterazine to the seedlings, images then were detectable by the EB-CCD camera for exposures of 5 min or less.
Microscope setup: In this arrangement, samples were viewed through an IX-71 inverted microscope (Olympus America Inc., Melville NY) with epifluorescence attachment, excitation (EX) 500/20 nm, emission (EM) 520 LP. The EB-CCD camera was coupled to the Dual-View image splitter, which was connected to the bottom port of the IX-71 microscope. The microscope (but not the EB-CCD camera or Dual-View) was placed in a light-tight, temperature-controlled box (the same controls in the absence of coelenterazine were performed for the microscope setup as mentioned above for the box setup with the same results). The entire microscope/apparatus was maintained at 22°C for plant tissue and at 36°C for mammalian cell imaging. The BRET images of blue light (<505 nm = B) and yellow light (>505 nm = Y) were acquired simultaneously through the Dual-View (dichroic = Q505LPxr, interference filters HQ505SP and HQ505LP, exposure time 5-10 min). The images acquired by the camera were 16-bit TIF files. For mammalian cells, 20 sequential 100-ms exposures were placed into a stack in ImageJ (version WCIF) and integrated by choosing the median value for each pixel over the sequence of 20 exposures. For luminescence imaging of plant seedlings and cells, a single exposure (5-7.5 min) was taken (because the imaging of plant seedlings and cells was at the limit of detection of the luminescence signal, integration of multiple exposures was not performed on the plant samples). Then for both plant and mammalian samples, background subtraction was performed with ImageJ by using a single pixel from the nonsample region of the image as a background value. As part of the background subtraction, the files are converted to 8-bit TIF format. Then, the Y and B images were aligned with ImageJ and a pixel-by-pixel ratio (Y¸B) was calculated with ImageJ. These numerical ratios were visualized with a pseudocolor look-up table (LUT) as displayed on our figures. In Fig. 3C , the absorption of an ethanol extract of total pigments from tobacco seedlings [both pigmented from light-grown (green) and essentially unpigmented from dark-grown (etiolated) seedlings] was measured. The absorption ratio 480:530 was 2.07 for green seedlings and 1.63 for etiolated seedlings. Therefore, to provide a correction factor: 2.07 ¸ 1.63 = 1.27. This correction factor correlates well with the inhibition of the 480-nm emission by the green tissue seen in Fig. 3B (when the 530-nm peak is normalized to 1.0 and assuming that the 480-and 530-nm peaks should be roughly equal), which is 1.31.
Correction of BRET emission for tissue absorption of light (tobacco):
Comparison of Native Coelenterazine, Deep Blue C, and ViviRen for BRET Imaging. In the experiments with plants depicted in Figs. 1-3 , we used native coelenterazine as the substrate for RLUC. Native coelenterazine is nontoxic and highly permeable to all cell types that we have tested (we obtained native coelenterazine from Nanolight). Recently, new analogs of coelenterazine have become available commercially that potentially are useful for BRET. Two of these, EnduRen (Promega) and Deep Blue C (BioSignal/PE), generate luminescence that was too dim to be useful for imaging under our conditions. On the other hand, ViviRen (Promega) has been useful for BRET imaging of single mammalian cells, as in Fig.  4 . ViviRen is a modified version of the coelenterazine analog, coelenterazine-h, to which ester groups have been added. The original design intention of ViviRen was to develop an inactive RLUC substrate that would not undergo autoluminescence due to oxidation (a significant problem for native coelenterazine in serum-containing medium, Fig. 6A ) but that would permeate into cells where intracellular esterases cleave the ester groups to generate active coelenterazine-h. In our tests, we find that ViviRen has slightly less autoluminescence than native coelenterazine in serum-containing medium for the first 15-20 min but that its autoluminescence level steadily increases so that after 20 min, it has more autoluminescence than native coelenterazine (Fig. 6A) . In serum-free medium, native coelenterazine has a brief burst of autoluminescence upon addition, but thereafter both native and ViviRen coelenterazine have low autoluminescence (Fig. 6A) . HEK293 cells transfected with BRET constructs have brighter luminescence when using ViviRen than when using native coelenterazine in serum-containing medium during the interval 5-50 min after addition (Fig. 6B) . At 10 min after addition, the signal from cells expressing hRLUC•Venus is 100´ higher than the autoluminescence when using ViviRen. The viability of cells was not significantly affected by treatment for 1-6 h with either native coelenterazine or ViviRen (Fig. 6C) . Therefore, for HEK293 cells in 10% FBS (i) signal:autoluminescence and (ii) signal stability were superior with ViviRen as compared with native coelenterazine, and it therefore was used in the imaging experiments depicted in Fig. 4 . On the other hand, ViviRen does not appear to be useful for BRET in plant seedlings. The autoluminescence of native and ViviRen coelenterazines in the simple salt medium (1/2 MS) was comparable to that of serum-free DMEM (Fig. 6A) , but ViviRen did not enhance the signal from tobacco seedlings expressing BRET constructs (Fig. 6B) . Native coelenterazine in1/2 MS medium allows a longterm, stable BRET signal from tobacco seedlings (Fig. 6B) .
Assay for the effect of substrates on mammalian cell viability: HEK293 cells were grown in 24-well plates to the same density overnight. The next day, the cells were washed, and the medium was changed to medium with or without serum. At this time the cells were 80% confluent. The cells were incubated for 1 h with different substrates: native coelenterazine, coelenterazine-h, and ViviRen. Coelenterazine and coelenterazine-h were dissolved in ethanol, and ViviRen was dissolved in DMSO. Final concentrations were 5 mM for coelenterazine and coelenterazine-h and 10 mM for ViviRen. After the incubation, the cells were harvested, and 0.1 ml of 0.4% (wt/vol) trypan blue was added to 0.1 ml of the cell suspension from each sample. The stained and unstained cells were counted by using a hemacytometer. Blue-stained cells were scored as nonviable, and unstained cells were scored as viable. Therefore, percentage viability = number of viable cells ¸ total number of cells.
BRET Ratio Is Independent of Luminescence Intensity. To demonstrate that the BRET ratio is not influenced by the level of total luminescence, we calculated the BRET ratio for cells of different total luminescence from the same image capture. 
